OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
7686$416.0058

HitoMile Co Ltd

Food Retail & DistributionVerified

HitoMile's capital structure is characterized by a market cap of ¥12,082,450,016 and a market price of ¥416 per share, with no dilution risk identified due to equal basic and diluted shares outstanding. The company's liquidity risk remains unassessed due to lack of balance-sheet inputs and absence of going-concern language in source documents. Profitability metrics show HitoMile's last actual EPS at ¥18.76, below the mean analyst estimate of ¥20.40, and revenue of ¥134.514 billion, below the mean estimate of ¥141 billion. The company's revenue concentration is primarily in Japan, with no disclosed international exposure, and its segments are Time Delivery, Route Delivery, and In-Store Sales. Growth trajectory indicates a potential increase in revenue, with the current fiscal year's actual revenue at ¥134.514 billion and the mean analyst estimate for the next fiscal year at ¥141 billion. However, the company's growth is constrained by its domestic focus and lack of international expansion. Risk factors include unassessed liquidity risk and the absence of going-concern language in source documents, which may indicate potential financial instability. The company has not disclosed any dilution sources, and no near-term dilution pressure is expected. Recent events include the company's rebranding from Kakuyasu Group Co Ltd to HitoMile Co Ltd, reflecting a strategic shift in its business operations. No recent filings or transcripts have been disclosed that indicate significant changes in the company's operations or financial status.

30-day price · 7686(missing data)
No daily-bar history available from current data sources. Alternate source pending.
Profile
CompanyHitoMile Co Ltd
Ticker7686.T
SectorConsumer Non-Cyclicals
BusinessFood & Drug Retailing
Industry groupFood & Drug Retailing
IndustryFood Retail & Distribution
AI analysis

Business. HitoMile Co Ltd operates as a holding company engaged in formulating management strategies and providing support to its group companies, with business segments including Time Delivery, Route Delivery, and In-Store Sales.

Classification. HitoMile is classified under the Consumer Non-Cyclicals economic sector, Food & Drug Retailing business sector, and Food Retail & Distribution industry with a confidence level of 0.92.

HitoMile's capital structure is characterized by a market cap of ¥12,082,450,016 and a market price of ¥416 per share, with no dilution risk identified due to equal basic and diluted shares outstanding. The company's liquidity risk remains unassessed due to lack of balance-sheet inputs and absence of going-concern language in source documents. Profitability metrics show HitoMile's last actual EPS at ¥18.76, below the mean analyst estimate of ¥20.40, and revenue of ¥134.514 billion, below the mean estimate of ¥141 billion. The company's revenue concentration is primarily in Japan, with no disclosed international exposure, and its segments are Time Delivery, Route Delivery, and In-Store Sales. Growth trajectory indicates a potential increase in revenue, with the current fiscal year's actual revenue at ¥134.514 billion and the mean analyst estimate for the next fiscal year at ¥141 billion. However, the company's growth is constrained by its domestic focus and lack of international expansion. Risk factors include unassessed liquidity risk and the absence of going-concern language in source documents, which may indicate potential financial instability. The company has not disclosed any dilution sources, and no near-term dilution pressure is expected. Recent events include the company's rebranding from Kakuyasu Group Co Ltd to HitoMile Co Ltd, reflecting a strategic shift in its business operations. No recent filings or transcripts have been disclosed that indicate significant changes in the company's operations or financial status.
Key takeaways
  • HitoMile's market cap and share price suggest a moderate valuation with no immediate dilution risk.
  • The company's actual EPS and revenue are below analyst estimates, indicating potential underperformance.
  • Revenue concentration in Japan and lack of international exposure may limit growth opportunities.
  • Unassessed liquidity risk and absence of going-concern language raise concerns about financial stability.
  • The company's rebranding indicates a strategic shift, but no recent events suggest significant operational changes.
  • --
  • ## RATIONALES
  • ```json
Financial snapshot
PeriodHA-latest
CurrencyJPY
Revenue
Gross profit
Operating income
Net income
R&D
SG&A
D&A
SBC
Operating cash flow
CapEx
Free cash flow
Total assets
Total liabilities
Total equity
Cash & equivalents
Long-term debt
Annual history (last 5)
PeriodRevenueOp IncomeNet IncomeFCF
FY0
FY-1
FY-2
FY-3
FY-4
PeriodGross %Op %Net %FCF %
FY0
FY-1
FY-2
FY-3
FY-4
PeriodAssetsEquityCashDebt
FY0
FY-1
FY-2
FY-3
FY-4
PeriodOCFCapExFCFSBC
FY0
FY-1
FY-2
FY-3
FY-4
Quarterly history (last 4)
PeriodRevenueOp IncomeNet IncomeFCF
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodGross %Op %Net %FCF %
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodAssetsEquityCashDebt
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodOCFCapExFCFSBC
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
Valuation
Market price$416.00
Market cap$12.08B
Enterprise value
P/E
Reported non-GAAP P/E
EV/Revenue
EV/Op income
EV/OCF
P/B
P/Tangible book
Tangible book
Net cash
Current ratio
Debt/Equity
ROA
ROE
Cash conversion
CapEx/Revenue
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskUnknown
  • Liquidity risk could not be assessed (no balance-sheet inputs and no going-concern language in source documents).
Industry benchmarks
Activity: Food & Drug Retailing · cohort 234 companies
Metric7686Activity
Op margin2.8% medp25 0.9% · p75 5.9%
Net margin1.8% medp25 0.3% · p75 3.6%
Gross margin24.1% medp25 13.8% · p75 31.4%
CapEx / revenue-2.0% medp25 -3.8% · p75 -1.0%
Debt / equity56.0% medp25 14.0% · p75 113.8%
Observations
IR observations
Mean EPS estimate20.40 JPY
Last actual EPS18.76 JPY
Mean revenue estimate141,000,000,000 JPY
Last actual revenue134,514,000,000 JPY
Source data
Underlying data the analysis-pipeline pulls and audits. Fetch timestamps + content hashes show when each source was last refreshed.
Company fundamentalsperiod FQ-7 · history via verified-market-data
no public URL
2026-05-10 06:34 UTC#33d58c0f
Market quoteclose JPY 416.00 · shares 0.03B diluted
no public URL
2026-05-10 06:34 UTC#8fb2f7c3
Source: analysis-pipeline (hybrid)Generated: 2026-05-10 06:35 UTCJob: 386dae97